Insert the needle into the AOD-9604 vial at a slight angle, with the needle tip pointed toward the inner wall of the vial
Many of the common side effects, such as nausea, diarrhea, and vomiting, are most common when starting Mounjaro or increasing the dose
The Phase 1b trial by Enebo et al
Uncommon (may affect up to 1 in 100 people) change in the way food or drink tastes fast pulse injection site reactions such as bruising, pain, irritation, itching and rash
GLP-1 also seem to act on the reward and satiety centers of the brain (more research is being done on exactly what mechanisms)
China approved the drug in June 2025, and the higher-dose application is already under review